Position in GILD
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$53,568
-$5,942 QoQ
Shares Held
424
-0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#2,055
of 2,266 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dunhill Financial, LLC holds $6,908,274 across 15 Drug Manufacturers - General names. GILD ranks #12 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
113,506 | $2,733,224 | |
| 2 | ABBV |
AbbVie Inc.
|
4,061 | $1,021,910 | |
| 3 | JNJ |
Johnson & Johnson
|
3,664 | $930,546 | |
| 4 | LLY |
ELI LILLY & Co
|
730 | $875,583 | |
| 5 | AMGN |
Amgen Inc
|
1,716 | $621,397 | |
| 6 | NVS |
Novartis AG
|
1,303 | $204,206 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,889 | $108,844 | |
| 8 | NVO |
Novo Nordisk A S
|
1,972 | $94,537 |
All Filings in GILD
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,568 | 424 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $59,510 | 427 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $125,440 | 1,022 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $111,777 | 1,007 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $101,002 | 911 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $115,411 | 1,030 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $86,735 | 939 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $72,940 | 870 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $50,291 | 733 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $51,787 | 707 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $55,896 | 690 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||